Where Will Pfizer Be in 10 Years?

Pfizer (PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the first to launch a coronavirus vaccine. That product, Comirnaty, and the treatment Paxlovid, released later, helped Pfizer's revenue reach a record level of $100 billion in 2022; the two products made up more than half of that.Now, though, with coronavirus product demand falling and losses of exclusivity ahead for some of Pfizer's other drugs, the company's revenue i ...